Page 401 - ACCCN's Critical Care Nursing

378 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

37. Shinde V, Bridges C, Uyeki T. Triple-reassortant swine influenza A (H1) in 63. Busse W, Lemanske R. Advances in immunology: asthma. New Eng J Med
humans in the United States, 2005–2009. New Engl J Med 2009; 360: 2001; 344(5): 350–62.
2616–25. 64. Bradding P, Walls A, Holgate S. The role of the mast cell in the patho-
38. Taubenberger J, Morens D. Influenza: the once and future pandemic. Public physiology of asthma. J All Clin Imm 2006; 117(6): 1277–84.
Health Report 2010; 125(Suppl3): 16–26. 65. Gern J, Lemanske R, Busse W. Early life origins of asthma. J Clin Invest 1999;
39. ANZICS Influenza Investigators. Critical care services and 2009 influenza in 104(7): 837–43.
Australia and New Zealand. New Eng J Med 2009; 361(20): 1925–34. 66. O’Sullivan S. Asthma death, CD+8 T cells & viruses. Proc ATS 2005; 2(2):
40. Salgado C, Gianetta E, Hayden F, Farr B. Preventing nosocomial influenza 162–5.
by improving the vaccine acceptance rate of clinicians. Inf Con and Hosp Epid 67. Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U et al. Worldwide trends
2004; 25(11): 923–8. in the prevalence of asthma symptoms: phase III of the International Study
41. Department of Health and Ageing, Australian Government. Infection Control of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62(9):
Recommendations 2009. Canberra: Department of Health and Ageing. 758–66.
[Cited August 2010]. Available from: http://www.healthemergency.gov.au/ 68. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality,
internet/healthemergency/publishing.nsf/Content/clinical-infection and disease heterogeneity. Chest 2002; 121(5Suppl): S121–26.
42. Ministry of Health. Infection prevention and control during an influenza pan- 69. Lowe A, Campbell D, Walker P, Farish S, Jackson B, Dharmage S. Clustering
demic. Wellington: NZ Ministry of Health. 2006. [Cited August 2010]. Avail- effects of chronic obstructive pulmonary disease specific quality of life in
able from: http://www.moh.govt.nz/moh.nsf/0/4013C98B3E5B384DCC hospitalized patients. Respirol 2003; 8(3): 339–43.
2571490017EC3D/$File/influena-pandemic.pdf 70. British Thoracic Society. Guidelines for the management of Chronic Obstruc-
43. World Health Organization. Clarification: Use of Masks by Health Care tive Pulmonary Disease. Thorax 1997; 52(Suppl 5): S1–28.
Workers in Pandemic Settings. In: WHO global influenza preparedness plan: 71. Reid DW, Soltani A, Johns DP, Bish R, Williams TJ, Burns GP, Walters EH.
The role of WHO and recommendations for national measures before and during Bronchodilator reversibility in Australian adults with chronic obstructive
pandemics. Switzerland: World Health Organization; 2005. pulmonary disease. Intern Med J 2003; 33(12): 572–7.
44. Erikson S, Martin G, Davis J, Matthay M, Eisner M; for the ARDS Network. 72. Lacasse Y, Maltais F, Goldstein R. Smoking cessation in pulmonary
Recent trends in acute lung injury mortality: 1996–2005. Crit Care Med 2009; rehabilitation: goal or prerequisite? J Cardiopulm Rehabil 2002; 22(3):
37(5): 1574–9. 148–53.
45. Chapman S, Robinson G, Stradling J, West S. Oxford handbook of respiratory 73. Croxton TL, Weinmann GG, Senior RM, Wise RA, Crapo JD, Buist AS.
medicine. New York: Oxford University Press; 2009. Clinical research in chronic obstructive pulmonary disease: needs and
46. Murray J, Matthay M, Luce J, Flick M. An expanded definition of the adult opportunities. Am J Respir Crit Care Med 2003; 167(8): 1142–9.
respiratory distress syndrome. Am Rev of Resp Dis 1988; 138(3): 720– 74. Regional COPD working group. COPD prevalence in 12 Asia-Pacific
23. countries and regions: Projections based on the COPD prevalence estima-
47. Bernard G, Artigas A, Brigham K, Carlet J, Falke K et al. The American– tion model. Respirol 2003; 8: 192–8.
European Consensus Conference on ARDS. Definitions, mechanisms, rele- 75. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for
vant outcomes, and clinical trial coordination. Am J Respiratory Crit Care Med the diagnosis, management, and prevention of chronic obstructive
1994; 149(3Pt1): 818–24. pulmonary disease: National Heart, Lung, and Blood Institute and
48. Phua J, Stewart R, Ferguson N. Acute respiratory distress syndrome World Health Organization Global Initiative for Chronic Obstructive
40 years later: time to revisit its definition. Crit Care Med 2008;36(10): Lung Disease (GOLD): executive summary. Respir Care 2001; 46(8):
2912–21. 798–825.
49. Esan A, Hess D, Raoof S, George L, Sessler C. Severe hypoxaemic respiratory 76. Bach PB, Brown C, Gland SE, McCrery DC. Management of acute
failure: part 1: ventilatory strategies. Chest 2010; 137(5): 1203–16. exacerbations of chronic obstructive pulmonary disease: a summary
50. Taccone P, Pesenti A, Latini R et al. Prone-Supine II Study Group. Prone and appraisal of published evidence. Ann Intern Med 2001; 134(7):
positioning in patients with moderate and severe acute respiratory 600–20.
distress syndrome: a randomized controlled trial. JAMA 2009; 302(18): 77. Chen JC, Mannino D. Worldwide epidemiology of chronic obstructive pul-
1977–84. monary disease. Curr Opin Pulmonary Med 1999; 5(2): 93.
51. Raoof S, Goulet K, Esan A, Hess D, Sessler C. Severe hypoxaemic respiratory 78. Chitkara RK, Sarinas P. Recent advances in diagnosis and management of
failure: part 2: nonventilatory strategies. Chest 2010; 137(6): 1437–48. chronic bronchitis and emphysema. Curr Opin Pulmonary Med 2002; 8(2):
52. Afshari A, Brok J, Moller A, Wetterslev J. Inhaled nitric oxide for acute respira- 126–36.
tory distress syndrome (ARDS) and acute lung injury in children and adults. 79. Gerald LB, Bailey W. Global initiative for chronic obstructive lung disease.
Cochrane Database Systematic Review 2010; (7): CD002787. J Cardiopulmonary Rehab 2002; 22(4): 234–44.
53. Bosma K, Taneja R, Lewis J. Pharmacotherapy for prevention and treatment 80. Gronkiewicz C, Borkgren-Okonek M. Acute exacerbations of COPD: nursing
of acute respiratory distress syndrome: current and experimental approaches. application of evidenced based guidelines. Crit Care Nurs Q 2004: 27(4):
Drugs 2010; 70(10): 1255–82. 336–52.
54. Tang B, Craig J, Eslick G, Seppelt I, McLean A. Use of corticosteroids in acute 81. Farquhar SL, Fantasia L. Pulmonary anatomy and physiology and the effects
lung injury and acute respiratory distress syndrome: a systematic review and of COPD. Home Health Nurse 2005: 23(3): 167–74.
meta-analysis. Crit Care Med 2009; 37(5): 1594–603. 82. Sietsema K. Cardiovascular limitations in chronic pulmonary disease.
55. Eachempati S, Hydo L, Shou J, Barie P. Outcomes of acute respiratory distress Med Sci Sports Exerc 2001; 33(7 Suppl): S656–61.
syndrome (ARDS) in elderly patients. Trauma 2007; 63(2): 344–50. 83. Mergoni M, Rossi A. Physiopathology of acute respiratory failure in COPD
56. National Asthma Council of Australia. National Asthma Handbook 06. 2006. and asthma. Minerva Anestesiol 2001; 67(4): 198–205.
[Cited November 2010]. Available from: http://www.nationalasthma.org.au/ 84. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD.
cms/images/stories/amh2006_web_5.pdf. Chest 2005; 128(4): 2640–66.
57. Barnard A. Management of an acute asthma attack. Aust Fam Phys 2005; 85. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD. Lung
34(7): 531–4. function and incident coronary heart disease: the Atherosclerosis Risk in
58. Tuxen D, Naughton M. Acute severe asthma. In: Bersten N, Soni N, eds. Oh’s Communities Study. Am J Epidemiol 2003; 158(12): 1171–81.
Intensive Care Manual. Oxford: Elsevier; 2009. p. 399–413. 86. Sin DD, Man S. Why are patients with chronic obstructive pulmonary disease
59. American Thoracic Society. Standards for the diagnosis and care of patients at increased risk of cardiovascular diseases? The potential role of systemic
with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; inflammation in chronic obstructive pulmonary disease. Circulation 2003;
152(Supp): S77–120. 107(11): 1514–19.
60. McKenzie DK, Frith PA, Burdon JG, Town GI. The COPDX Plan: Australian 87. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM et al. Inspiratory-
& New Zealand Guidelines for the management of chronic obstructive pul- to-total lung capacity ratio predicts mortality in patients with chronic
monary disease 2003. Med J Aust 2003; 178(Supp): S7–39. obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(6):
61. McKenzie DK, Abramson M, Crockett AJ, Glasgow N, Jenkins S et al. The 591–7.
COPD-X Plan: Australian and New Zealand guidelines for the management 88. Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A et al. Breathing pattern
of chronic obstructive pulmonary disease 2010. [Cited November 2010]. and gas exchange at peak exercise in COPD patients with and without tidal
Available from: http://www.copdx.org.au/home flow limitation at rest. Euro Resp J 2001; 17(6): 1120–27.
62. Leidy N. Functional performance in people with chronic obstructive pul- 89. Sutherland ER, Cherniack R. Management of chronic obstructive pulmonary
monary disease. Image J Nurs Sch 1995; 27(1): 23–34. disease. New Engl J Med 2004; 350(26): 2689–97.